Screener
Rigel Pharmaceuticals RIGL Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's current ratio?
- Rigel Pharmaceuticals (RIGL) reported current ratio of 2.6× in Q1 2026.
- How has Rigel Pharmaceuticals's current ratio changed year-over-year?
- Rigel Pharmaceuticals's current ratio increased by 18.9% year-over-year, from 2.2× to 2.6×.
- What is the long-term trend for Rigel Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's current ratio has grown at a 2.1% compound annual growth rate (CAGR), from 2.2× to 2.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Rigel Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude